Search - tctmd.com

Displaying 61 - 80 of 100

Sort: Relevancy | Date

Presentation TCT 2014

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

Presenter: Clemens von Birgelen

September 16, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms VII: MiStent

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, John A. Ormiston

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Shigeru Saito

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Bo Xu

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Pedro A. Lemos

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms I: BioMime

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Ricardo A. Costa

September 15, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

July 24, 2013

Presentation TCTAP 2013

Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-Eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry

Presenter: Jung-Min Ahn

April 25, 2013

Presentation ACC 2013

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Presenter: Ian T. Meredith

March 09, 2013

Advertisement

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

Cobalt-Chromium Sirolimus-Eluting Platforms VII: MiStent

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Cobalt-Chromium Sirolimus-Eluting Platforms I: BioMime

COMPARE II: BES, EES Show Similar Outcomes at Three Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Contemporary ZES Perform Well in Treating In-Stent Restenosis

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-Eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content